Literature DB >> 31144425

Gut epithelial and vascular barrier abnormalities in patients with chronic intestinal pseudo-obstruction.

Elisa Boschetti1, Anna Accarino2, Carolina Malagelada2, Juan R Malagelada2, Rosanna F Cogliandro1, Alessandra Gori1, Vitaliano Tugnoli3, Fiorella Giancola1, Francesca Bianco1, Elena Bonora1, Paolo Clavenzani4, Umberto Volta1, Giacomo Caio5, Catia Sternini6, Vincenzo Stanghellini1, Fernando Azpiroz2, Roberto De Giorgio5.   

Abstract

BACKGROUND: Chronic intestinal pseudo-obstruction (CIPO) is a rare condition due to severe impairment of gut motility responsible for recurrent subocclusive episodes. Although neuromuscular-glial-ICC abnormalities represent the main pathogenetic mechanism, the pathophysiology of CIPO remains poorly understood. Intestinal epithelial and vascular endothelial barrier (IEVB) abnormalities can contribute to neuroepithelial changes by allowing passage of harmful substances.
METHODS: To test retrospectively whether IEVB defects occur in patients with CIPO, we measured the jejunal protein expression of the major tight junction (TJ) components. CIPO patients were subdivided according to gut neuromuscular histopathology: apparently normal (AN); with inflammation (INF); or with degenerative alterations (DEG). The presence of occludin/claudin oligomers (index of TJ assembly), the amount of occludin, claudin-4, and zonula occludens-1 (ZO-1), and the expression of vasoactive intestinal polypeptide (VIP) and glial fibrillary acidic protein (GFAP) immunoreactivities were evaluated on jejunal full-thickness biopsies using Western blot. KEY
RESULTS: Oligomers were absent in the 73% of CIPO. Total occludin decreased in CIPO with AN and INF changes. Claudin-4 was upregulated in CIPO with INF and DEG features. ZO-1 and VIP expression decreased selectively in DEG group. GFAP increased in CIPO regardless the histopathological phenotype. CONCLUSIONS & INFERENCES: The absence of oligomers demonstrated in our study suggests that IEBV is altered in CIPO. The mechanism leading to oligomerization is occludin-dependent in AN and INF, whereas is ZO-1-dependent in DEG. Our study provides support to IEVB abnormalities contributing to CIPO clinical and histopathological features.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic intestinal pseudo-obstruction; intestinal epithelial barrier; intestinal vascular barrier; severe dysmotility; tight junction

Year:  2019        PMID: 31144425      PMCID: PMC6639131          DOI: 10.1111/nmo.13652

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  40 in total

1.  Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.

Authors:  T Kucharzik; S V Walsh; J Chen; C A Parkos; A Nusrat
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 2.  Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy.

Authors:  Roberto De Giorgio; Rosanna F Cogliandro; Giovanni Barbara; Roberto Corinaldesi; Vincenzo Stanghellini
Journal:  Gastroenterol Clin North Am       Date:  2011-12       Impact factor: 3.806

3.  The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group.

Authors:  Charles H Knowles; Roberto De Giorgio; Raj P Kapur; Elisabeth Bruder; Gianrico Farrugia; Karel Geboes; Greger Lindberg; Joanne E Martin; William A Meier-Ruge; Peter J Milla; Virpi V Smith; Jean Marie Vandervinden; Béla Veress; Thilo Wedel
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

Review 4.  Transmembrane proteins of tight junctions.

Authors:  Hideki Chiba; Makoto Osanai; Masaki Murata; Takashi Kojima; Norimasa Sawada
Journal:  Biochim Biophys Acta       Date:  2007-09-04

Review 5.  Intestinal mucosal barrier function in health and disease.

Authors:  Jerrold R Turner
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

6.  Astrocytic tight junctions control inflammatory CNS lesion pathogenesis.

Authors:  Sam Horng; Anthony Therattil; Sarah Moyon; Alexandra Gordon; Karla Kim; Azeb Tadesse Argaw; Yuko Hara; John N Mariani; Setsu Sawai; Per Flodby; Edward D Crandall; Zea Borok; Michael V Sofroniew; Candice Chapouly; Gareth R John
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

7.  Altered expression of occludin and tight junction formation in psoriasis.

Authors:  Y Yoshida; K Morita; A Mizoguchi; C Ide; Y Miyachi
Journal:  Arch Dermatol Res       Date:  2001-05       Impact factor: 3.017

8.  Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility.

Authors:  C Malagelada; T B Karunaratne; A Accarino; R F Cogliandro; S Landolfi; A Gori; E Boschetti; J R Malagelada; V Stanghellini; F Azpiroz; R De Giorgio
Journal:  Neurogastroenterol Motil       Date:  2017-09-22       Impact factor: 3.598

9.  Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.

Authors:  V S Conlin; X Wu; C Nguyen; C Dai; B A Vallance; A M J Buchan; L Boyer; K Jacobson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-08-06       Impact factor: 4.052

10.  Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione.

Authors:  Tor C Savidge; Paul Newman; Charalabos Pothoulakis; Anne Ruhl; Michel Neunlist; Arnaud Bourreille; Roger Hurst; Michael V Sofroniew
Journal:  Gastroenterology       Date:  2007-02-01       Impact factor: 22.682

View more
  2 in total

Review 1.  Related Effects of Methamphetamine on the Intestinal Barrier via Cytokines, and Potential Mechanisms by Which Methamphetamine May Occur on the Brain-Gut Axis.

Authors:  Yuansen Li; Deshenyue Kong; Ke Bi; Huayou Luo
Journal:  Front Med (Lausanne)       Date:  2022-05-10

Review 2.  The blood-brain and gut-vascular barriers: from the perspective of claudins.

Authors:  Anna Agata Scalise; Nikolaos Kakogiannos; Federica Zanardi; Fabio Iannelli; Monica Giannotta
Journal:  Tissue Barriers       Date:  2021-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.